Search Orphan Drug Designations and Approvals
-
Generic Name: | bivalirudin |
---|---|
Date Designated: | 11/02/2005 |
Orphan Designation: | For use as an anticoagulant in patients with or at risk of heparin-induced thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
The Medicines Company 8 Sylvan Way Parsippany, New Jersey 07054 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-